Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Composite MR Neuroimaging Marker for Alzheimer's Disease
Authors not listed
Medical College of Wisconsin · 2009
Abstract
The purpose of this study is to use a functional MRI (fMRI) index to compare the brain activity of healthy volunteers to that of people with mild cognitive impairment (MCI) and Alzheimer's disease. The ultimate goal is to develop an early diagnostic tool for Alzheimer's disease.
The study hypotheses are:
1. The fMRI index will differentiate between Alzheimer's disease, non-Alzheimer's dementia, and healthy volunteers;
2. The fMRI index will distinguish participants with MCI who convert to Alzheimer's disease from those who convert to a non-Alzheimer's dementia and those who remain stable;
3. MCI participants with a lower fMRI index at baseline who convert will progress to Alzheimer's sooner than those with a higher fMRI index, and MCI participants with a faster rate of fMRI index decline who convert will have an earlier onset of Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2009). A Composite MR Neuroimaging Marker for Alzheimer's Disease. <em>Medical College of Wisconsin</em>. https://clinicaltrials.gov/study/NCT01615666
Vancouver
Anonymous. A Composite MR Neuroimaging Marker for Alzheimer's Disease. Medical College of Wisconsin. 2009.
BibTeX
@misc{anon2009ACompo,
title = {A Composite MR Neuroimaging Marker for Alzheimer's Disease},
author = {Anonymous},
journal = {Medical College of Wisconsin},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University Hospital, Strasbourg, France 2012
Open access · US-GOV
Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.
Chinese PLA General Hospital 2025
Open access · US-GOV
Ultra-high Field Multimodal and Multinuclear Neuroimaging Cohort Study of Alzheimer's Disease
Masaryk University 2018
Open access · US-GOV
Modulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Cell Death and Differentiation 2008
Citation only